Shandong Keyuan Pharmaceutical Co., Ltd.，a core healthcare manufaturer with the Linuo Group,was incorporated in 2004. It is dedicated to the development,manufacture and marketing of active pharmaceutical ingredients (APLs),and operates a customized manufacturing (CMO) business.
Keyuan pharma has established strategic cooperation with dozens of internationally renowned pharmaceutical companies.
In March 2016,Keyan Pharma was successfully listed on China's National Equities Exchange and Quotations(NEEQ), attracting investment form financial institutions and substantially boosting the development of the business.
Keyuan Pharma,adhering to the principles of health,safety and environment(HSE),aims to be the largest production base for diabetic ,cardiovascular and anesthetic agents in China.